The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP49064-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to agomelatine TSA212432-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine TSA212472-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine TSA212519-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine TSA212571-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine TSA212623-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine TSA212672-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine TSA212724-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine TSA212777-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine TSA212829-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine TSA212865-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine TSA212913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine TSA212949-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine TSA212993-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine TSA213043-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine TSF496799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF496800-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF496801-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF496802-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF496803-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF496804-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF602985-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF602986-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF602987-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF602988-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF602989-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF602990-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF497080-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF497079-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF497083-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF497081-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF497082-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF497084-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF603325-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF603320-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF603321-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF603322-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF603323-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF603324-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF497374-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF497370-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF497371-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF497372-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF497373-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF497375-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF603649-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF603650-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF603651-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF603652-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF603653-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF603654-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF497684-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF497685-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF497686-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF497687-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF497688-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF497689-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF603988-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF603985-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF603989-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF603986-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF603987-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF603990-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF498003-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF497999-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF498000-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF498001-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF498002-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF498004-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF604314-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF604315-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF604316-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF604317-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF498300-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF498296-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF498297-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF498298-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF498299-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF498301-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF604641-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF604642-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF604640-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF604643-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF604644-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF604645-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF498616-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF498611-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF498612-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF498613-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF498614-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF498615-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF604976-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF604977-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF604978-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF604979-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF604980-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF604981-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF498932-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF498933-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF498934-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF498935-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF498936-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF498937-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF499248-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF499251-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF499249-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF499250-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF499252-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF499253-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF605312-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF605313-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF605314-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF605315-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF605316-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF605317-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF499526-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF499527-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF499528-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF499529-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF499530-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF499531-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF605640-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF605641-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF605642-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF605643-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF605644-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF605645-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF499836-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF499840-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF499837-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF499838-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF499839-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF499841-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF605974-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF605973-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF605975-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF605976-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF605977-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF605978-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF500106-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF500107-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF500110-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF500108-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF500109-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF500111-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF606304-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF606305-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF606303-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF606308-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSF606306-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF606307-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF500408-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF500409-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF500410-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF500411-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF500412-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF500413-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF500726-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.37 µM for 24.0 h 1 subfactor(s) TSF500723-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 10.0 µM for 24.0 h 1 subfactor(s) TSF500724-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 3.33 µM for 24.0 h 1 subfactor(s) TSF500727-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.125 µM for 24.0 h 1 subfactor(s) TSF500725-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 1.11 µM for 24.0 h 1 subfactor(s) TSF500728-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.04 µM for 24.0 h 1 subfactor(s) TSF606633-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 2.22 µM for 24.0 h 1 subfactor(s) TSF606634-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.74 µM for 24.0 h 1 subfactor(s) TSF606635-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.25 µM for 24.0 h 1 subfactor(s) TSF606636-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.08 µM for 24.0 h 1 subfactor(s) TSF606637-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.03 µM for 24.0 h 1 subfactor(s) TSF606638-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.01 µM for 24.0 h 1 subfactor(s) TSS496808-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 10.0 µM for 24.0 h TSS496809-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 3.33 µM for 24.0 h TSS496810-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 1.11 µM for 24.0 h TSS496811-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.37 µM for 24.0 h TSS496812-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.125 µM for 24.0 h TSS496813-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.04 µM for 24.0 h TSS602996-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 2.22 µM for 24.0 h TSS602997-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.74 µM for 24.0 h TSS602998-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.25 µM for 24.0 h TSS602999-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.08 µM for 24.0 h TSS603000-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.03 µM for 24.0 h TSS603001-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to agomelatine 0.01 µM for 24.0 h TSS497089-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 3.33 µM for 24.0 h TSS497088-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 10.0 µM for 24.0 h TSS497092-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.125 µM for 24.0 h TSS497090-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 1.11 µM for 24.0 h TSS497091-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.37 µM for 24.0 h TSS497093-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.04 µM for 24.0 h TSS603336-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.01 µM for 24.0 h TSS603331-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 2.22 µM for 24.0 h TSS603332-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.74 µM for 24.0 h TSS603333-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.25 µM for 24.0 h TSS603334-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.08 µM for 24.0 h TSS603335-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to agomelatine 0.03 µM for 24.0 h TSS497383-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.125 µM for 24.0 h TSS497379-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 10.0 µM for 24.0 h TSS497380-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 3.33 µM for 24.0 h TSS497381-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 1.11 µM for 24.0 h TSS497382-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.37 µM for 24.0 h TSS497384-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.04 µM for 24.0 h TSS603660-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 2.22 µM for 24.0 h TSS603661-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.74 µM for 24.0 h TSS603662-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.25 µM for 24.0 h TSS603663-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.08 µM for 24.0 h TSS603664-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.03 µM for 24.0 h TSS603665-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to agomelatine 0.01 µM for 24.0 h TSS497693-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 10.0 µM for 24.0 h TSS497694-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 3.33 µM for 24.0 h TSS497695-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 1.11 µM for 24.0 h TSS497696-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.37 µM for 24.0 h TSS497697-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.125 µM for 24.0 h TSS497698-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.04 µM for 24.0 h TSS603999-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.08 µM for 24.0 h TSS603996-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 2.22 µM for 24.0 h TSS604000-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.03 µM for 24.0 h TSS603997-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.74 µM for 24.0 h TSS603998-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.25 µM for 24.0 h TSS604001-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to agomelatine 0.01 µM for 24.0 h TSS498012-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.125 µM for 24.0 h TSS498008-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 10.0 µM for 24.0 h TSS498009-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 3.33 µM for 24.0 h TSS498010-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 1.11 µM for 24.0 h TSS498011-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.37 µM for 24.0 h TSS498013-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.04 µM for 24.0 h TSS604325-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.25 µM for 24.0 h TSS604326-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.08 µM for 24.0 h TSS604327-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.03 µM for 24.0 h TSS604328-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to agomelatine 0.01 µM for 24.0 h TSS498309-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.125 µM for 24.0 h TSS498305-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 10.0 µM for 24.0 h TSS498306-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 3.33 µM for 24.0 h TSS498307-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 1.11 µM for 24.0 h TSS498308-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.37 µM for 24.0 h TSS498310-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.04 µM for 24.0 h TSS604652-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.74 µM for 24.0 h TSS604653-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.25 µM for 24.0 h TSS604651-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 2.22 µM for 24.0 h TSS604654-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.08 µM for 24.0 h TSS604655-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.03 µM for 24.0 h TSS604656-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to agomelatine 0.01 µM for 24.0 h TSS498625-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.04 µM for 24.0 h TSS498620-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 10.0 µM for 24.0 h TSS498621-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 3.33 µM for 24.0 h TSS498622-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 1.11 µM for 24.0 h TSS498623-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.37 µM for 24.0 h TSS498624-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.125 µM for 24.0 h TSS604987-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 2.22 µM for 24.0 h TSS604988-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.74 µM for 24.0 h TSS604989-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.25 µM for 24.0 h TSS604990-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.08 µM for 24.0 h TSS604991-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.03 µM for 24.0 h TSS604992-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to agomelatine 0.01 µM for 24.0 h TSS498941-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 10.0 µM for 24.0 h TSS498942-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 3.33 µM for 24.0 h TSS498943-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 1.11 µM for 24.0 h TSS498944-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 0.37 µM for 24.0 h TSS498945-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 0.125 µM for 24.0 h TSS498946-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to agomelatine 0.04 µM for 24.0 h TSS499257-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 10.0 µM for 24.0 h TSS499260-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.37 µM for 24.0 h TSS499258-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 3.33 µM for 24.0 h TSS499259-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 1.11 µM for 24.0 h TSS499261-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.125 µM for 24.0 h TSS499262-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.04 µM for 24.0 h TSS605323-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 2.22 µM for 24.0 h TSS605324-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.74 µM for 24.0 h TSS605325-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.25 µM for 24.0 h TSS605326-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.08 µM for 24.0 h TSS605327-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.03 µM for 24.0 h TSS605328-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to agomelatine 0.01 µM for 24.0 h TSS499535-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 10.0 µM for 24.0 h TSS499536-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 3.33 µM for 24.0 h TSS499537-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 1.11 µM for 24.0 h TSS499538-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.37 µM for 24.0 h TSS499539-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.125 µM for 24.0 h TSS499540-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.04 µM for 24.0 h TSS605651-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 2.22 µM for 24.0 h TSS605652-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.74 µM for 24.0 h TSS605653-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.25 µM for 24.0 h TSS605654-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.08 µM for 24.0 h TSS605655-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.03 µM for 24.0 h TSS605656-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to agomelatine 0.01 µM for 24.0 h TSS499845-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 10.0 µM for 24.0 h TSS499849-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.125 µM for 24.0 h TSS499846-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 3.33 µM for 24.0 h TSS499847-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 1.11 µM for 24.0 h TSS499848-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.37 µM for 24.0 h TSS499850-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.04 µM for 24.0 h TSS605985-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.74 µM for 24.0 h TSS605984-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 2.22 µM for 24.0 h TSS605986-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.25 µM for 24.0 h TSS605987-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.08 µM for 24.0 h TSS605988-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.03 µM for 24.0 h TSS605989-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to agomelatine 0.01 µM for 24.0 h TSS500115-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 10.0 µM for 24.0 h TSS500116-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 3.33 µM for 24.0 h TSS500119-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.125 µM for 24.0 h TSS500117-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 1.11 µM for 24.0 h TSS500118-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.37 µM for 24.0 h TSS500120-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.04 µM for 24.0 h TSS606315-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.74 µM for 24.0 h TSS606316-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.25 µM for 24.0 h TSS606314-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 2.22 µM for 24.0 h TSS606319-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.01 µM for 24.0 h TSS606317-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.08 µM for 24.0 h TSS606318-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to agomelatine 0.03 µM for 24.0 h TSS500417-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 10.0 µM for 24.0 h TSS500418-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 3.33 µM for 24.0 h TSS500419-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 1.11 µM for 24.0 h TSS500420-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 0.37 µM for 24.0 h TSS500421-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 0.125 µM for 24.0 h TSS500422-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to agomelatine 0.04 µM for 24.0 h TSS500735-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.37 µM for 24.0 h TSS500732-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 10.0 µM for 24.0 h TSS500733-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 3.33 µM for 24.0 h TSS500736-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.125 µM for 24.0 h TSS500734-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 1.11 µM for 24.0 h TSS500737-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.04 µM for 24.0 h TSS606644-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 2.22 µM for 24.0 h TSS606645-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.74 µM for 24.0 h TSS606646-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.25 µM for 24.0 h TSS606647-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.08 µM for 24.0 h TSS606648-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.03 µM for 24.0 h TSS606649-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to agomelatine 0.01 µM for 24.0 h
TSP49064 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to agomelatine
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided